Debra Durso Bumpus Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Debra Durso Bumpus is CHIEF PEOPLE OFFICER of Blueprint Medicines Corp. Currently has a direct ownership of 43,763 shares of BPMC, which is worth approximately $3.82 Million. The most recent transaction as insider was on Jul 05, 2024, when has been sold 3,850 shares (Common Stock) at a price of $111.2 per share, resulting in proceeds of $428,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.8K
0% 3M change
12.78% 12M change
Total Value Held $3.82 Million

Debra Durso-Bumpus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 05 2024
SELL
Open market or private sale
$428,120 $111.2 p/Share
3,850 Reduced 8.09%
43,763 Common Stock
Jul 05 2024
BUY
Exercise of conversion of derivative security
$208,400 $54.13 p/Share
3,850 Added 7.48%
47,613 Common Stock
Jul 03 2024
SELL
Open market or private sale
$981,243 $111.29 p/Share
8,817 Reduced 16.77%
43,763 Common Stock
Jul 03 2024
BUY
Exercise of conversion of derivative security
$477,264 $54.13 p/Share
8,817 Added 14.36%
52,580 Common Stock
Jun 28 2024
SELL
Open market or private sale
$37,012 $111.15 p/Share
333 Reduced 0.76%
43,763 Common Stock
Jun 28 2024
BUY
Exercise of conversion of derivative security
$18,025 $54.13 p/Share
333 Added 0.75%
44,096 Common Stock
Jun 21 2024
SELL
Open market or private sale
$7,706,199 $104.09 p/Share
74,034 Reduced 62.85%
43,763 Common Stock
Jun 21 2024
BUY
Exercise of conversion of derivative security
$1,908,207 $31.55 p/Share
60,482 Added 33.93%
117,797 Common Stock
Mar 07 2024
SELL
Open market or private sale
$461,884 $90.69 p/Share
5,093 Reduced 8.13%
57,585 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
12,500 Added 16.63%
62,678 Common Stock
Mar 06 2023
SELL
Open market or private sale
$142,110 $45.0 p/Share
3,158 Reduced 5.92%
50,178 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
12,500 Added 18.99%
53,336 Common Stock
Aug 24 2022
SELL
Open market or private sale
$375,550 $75.11 p/Share
5,000 Reduced 10.91%
40,836 Common Stock
Aug 24 2022
BUY
Exercise of conversion of derivative security
$75,050 $15.01 p/Share
5,000 Added 9.84%
45,836 Common Stock
Mar 07 2022
SELL
Open market or private sale
$58,831 $56.19 p/Share
1,047 Reduced 2.5%
40,836 Common Stock
Mar 03 2022
SELL
Open market or private sale
$89,863 $60.27 p/Share
1,491 Reduced 3.44%
41,883 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 22.37%
43,374 Common Stock
Nov 01 2021
SELL
Open market or private sale
$584,535 $112.91 p/Share
5,177 Reduced 14.36%
30,874 Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
$139,934 $27.03 p/Share
5,177 Added 12.56%
36,051 Common Stock
Sep 23 2021
SELL
Open market or private sale
$93,288 $110.01 p/Share
848 Reduced 2.67%
30,874 Common Stock
Sep 23 2021
BUY
Exercise of conversion of derivative security
$30,570 $36.05 p/Share
848 Added 2.6%
31,722 Common Stock
Mar 04 2021
SELL
Open market or private sale
$148,628 $87.79 p/Share
1,693 Reduced 5.2%
30,874 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
13,062 Added 28.63%
32,567 Common Stock
DD

Debra Durso Bumpus

CHIEF PEOPLE OFFICER
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC